## Clinical Diagnosis This patient has **acute biliary pancreatitis with choledocholithiasis** (obstructive pancreatitis). **Key Point:** Biliary pancreatitis accounts for 40–50% of acute pancreatitis cases in developed countries. Elevated liver enzymes (ALT > AST, elevated ALP, hyperbilirubinemia) with imaging evidence of CBD obstruction confirm biliary etiology. ### Diagnostic Criteria Met - Acute pancreatitis: elevated amylase/lipase - Biliary obstruction: hyperbilirubinemia (direct predominant), elevated transaminases, CBD stone on ultrasound - Cholestasis pattern: ALP mildly elevated (120 U/L) relative to transaminases ## Management Algorithm ```mermaid flowchart TD A[Acute Biliary Pancreatitis + CBD Stone]:::outcome --> B{Cholangitis present?}:::decision B -->|Yes: fever, RUQ tenderness, elevated WBC| C[ERCP within 24 hours]:::action B -->|No cholangitis| D{Pancreatitis severity?}:::decision D -->|Mild-moderate| E[ERCP within 24-48 hours]:::action D -->|Severe with organ failure| F[Stabilize first, then ERCP within 48-72 hours]:::action C --> G[Sphincterotomy + stone extraction]:::action E --> G F --> G G --> H[Post-ERCP: supportive care]:::action H --> I[Elective cholecystectomy within 2 weeks]:::action ``` **High-Yield:** In biliary pancreatitis WITH persistent CBD obstruction (stone visible on imaging), ERCP should be performed within **24 hours** to relieve obstruction and prevent severe pancreatitis progression. ## Timing of ERCP | Scenario | Timing | Rationale | |----------|--------|----------| | Biliary pancreatitis + CBD stone (this case) | Within 24 hours | Relieve obstruction, reduce severity | | Biliary pancreatitis + no CBD stone | Within 48–72 hours or electively | Obstruction likely self-limited | | Acute cholangitis + pancreatitis | Within 24 hours (urgent) | Sepsis risk | | Severe pancreatitis + coagulopathy | Stabilize first, then ERCP within 48–72 hours | Reduce bleeding risk | **Clinical Pearl:** ERCP is both diagnostic and therapeutic in this setting. Sphincterotomy reduces intraductal pressure and allows stone passage, terminating the pancreatitis trigger. ## Post-ERCP Management 1. **Cholecystectomy:** Performed electively within 2 weeks to prevent recurrent pancreatitis 2. **Supportive care:** Continue IV fluids, NPO, analgesia, monitoring for post-ERCP pancreatitis (5–10% risk) 3. **Follow-up imaging:** Repeat ultrasound or MRCP if symptoms persist **Warning:** Post-ERCP pancreatitis can occur even with successful stone extraction. Monitor amylase/lipase and clinical status. ## Why NOT Other Options - **PTC:** Second-line for failed ERCP or intrahepatic cholestasis; not first-line for CBD stones - **Surgery:** Cholecystectomy is deferred until after ERCP and pancreatitis resolution to reduce operative risk - **Delayed ERCP:** Persistent obstruction worsens pancreatitis; early intervention improves outcomes [cite:Harrison 21e Ch 347, Ch 310] ## Mnemonic: ERCP Indications in Pancreatitis **ERCP-FAST:** - **E**mergent (cholangitis) - **R**ecurrent biliary pancreatitis - **C**holedocholithiasis with obstruction - **P**ersistent jaundice - **F**ailed conservative management - **A**cute biliary obstruction - **S**evere pancreatitis from bile duct obstruction - **T**ranspapillary therapy needed
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.